OpenAlex
PricingAboutJobs
Log inGet started
Work

Can Targeting the Incretin Pathway Dampen RAGE-Mediated Events in Diabetic Nephropathy?

HTML

Year: 2016
Type: article
Source: Current Drug Targets
DOI: 10.2174/1389450116666150722141418
Authors: Karly C. Sourris, Henry Yao, George Jerums, Mark E.Cooper, Elif I. Ekinci, Melinda T. Coughlan
Institutions: Baker Heart and Diabetes Institute, Austin Health, The University of Melbourne, Royal Prince Alfred Hospital, The Alfred Hospital, Charles Darwin University, Alfred Health
Language: English

Topic: Advanced Glycation End Products research
Subfield: Clinical Biochemistry
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: diabetic nephropathy, receptor for advanced glycation end products, RAGE, GLP-1 receptor agonists, renal protection, reactive oxygen species, inflammation, renal fibrosis, type 2 diabetes, renin-angiotensin system
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W1825315788
FWCI: 0.625
Cites:
Cited by: 21
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security